HOME > MARKETS > BIG PHARMAS
Big Pharmas
NEUROSERVICE: THE PARTNER OF YOUR CNS AND PAIN R&D PROGRAMS FOR IN VITRO ELECTROPHYSIOLOGY.
NEUROSERVICE aims at supporting Pharmaceutical Companies at each step of their Drug Development process by evaluating any compound effects on the CNS thanks to a wide range of electrophysiological-based assays in acute slices (brain and spinal cord).
- Molecule effects on Neurons & Neuronal networks down to receptor or channel levels
- Targets & Mechanisms of Action (MOA)
- Dose-response protocols
- Dose-inhibition protocols
- Characterization of allosteric modulators
- Interaction of a new molecule with an existing drug (in vitro drug-drug interaction)
- Synaptic transmission
- Synaptic plasticity
- Pro-convulsive effect
The mission of NEUROSERVICE is to provide smart CNS electrophysiological data to empower the scientific analysis in the research programs:
- Hit or lead selection
- Compound profiling
- Transgenic mice profiling
A quality of service and a wide range of contractual solutions enable NEUROSERVICE to become a long-term partner and the outsourcing solution for CNS R&D programs.
